子宮内避妊器具(IUD)の世界市場2022-2028:産業動向、シェア、規模、成長、機会・予測

◆英語タイトル:Intrauterine Devices (IUD) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書(IMARC23FE0044)◆商品コード:IMARC23FE0044
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年2月1日
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社発行の当調査資料によると、2022年43億ドルであった世界の子宮内避妊器具(IUD)市場規模が2028年には57億ドルに達し、予測期間中、年平均4.75%成長すると予測されています。当書は、子宮内避妊器具(IUD)の世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別(ホルモン性子宮内避妊器具、銅製子宮内避妊具)分析、エンドユーザー別(病院、婦人科クリニック、地域医療、その他)分析、地域別(ヨーロッパ、北米、アジア太平洋、中東/アフリカ、中南米)分析、製造プロセス、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Actavis、Bayer、Teva Pharmaceuticals、Allergan、Eurogine、OCON Medical、Pregna、HLL Lifecare、HRA Pharma、ANI Pharmaceuticals、Besins HealthCare、SMBなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界の子宮内避妊器具(IUD)市場規模:製品別
- ホルモン性子宮内避妊器具の市場規模
- 銅製子宮内避妊具の市場規模

・世界の子宮内避妊器具(IUD)市場規模:エンドユーザー別
- 病院における市場規模
- 婦人科クリニックにおける市場規模
- 地域医療における市場規模
- その他エンドユーザーにおける市場規模

・世界の子宮内避妊器具(IUD)市場規模:地域別
- ヨーロッパの子宮内避妊器具(IUD)市場規模
- 北米の子宮内避妊器具(IUD)市場規模
- アジア太平洋の子宮内避妊器具(IUD)市場規模
- 中東/アフリカの子宮内避妊器具(IUD)市場規模
- 中南米の子宮内避妊器具(IUD)市場規模

・製造プロセス
・競争状況
・主要企業情報

The global intrauterine devices market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028.

An intrauterine device (IUD) is a T-shaped plastic or copper birth control medical device inserted into the uterus to prevent pregnancy. It releases copper into the womb, which alters the cervical mucus and makes it difficult for the sperm to reach an egg and survive. It can also stop a fertilized egg from being able to implant itself. As it is compact, safe and cost-effective and has no hormonal side effects, such as acne, headaches, or breast tenderness, IUD is widely preferred over other methods of contraception. At present, it is available in different types that can last for an extended period of 5 to 10 years.

Intrauterine Devices Market Trends:
Increasing cases of unplanned and unwanted pregnancies represent one of the key factors positively influencing the demand for IUDs across the globe. In addition, hormonal IUDs can be used to treat people suffering from severe cramps, heavy periods, and anemia. Apart from this, initiatives undertaken by health agencies of numerous countries, along with non-profit organizations (NPOs), to generate awareness about family planning; the advantages of birth control measures; and health-related issues caused by unplanned pregnancies are promoting the market growth. In addition, as IUDs have an extremely low risk of ectopic pregnancy, they are gaining immense traction among nulliparous women and adolescents who have never given birth and are at higher risk for adverse birth outcomes like breast and reproductive cancers. Besides this, the development of advanced product variants, such as postpartum, slimmer and reusable IUDs, with fewer side effects is anticipated to offer lucrative growth opportunities to industry investors in the coming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intrauterine devices market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product and end-use.

Breakup by Product:

Hormonal Intrauterine Device
Copper Intrauterine Device

Hormonal intrauterine devices hold the majority of the global intrauterine devices market share as they are cost-effective and long-lasting and can be used to treat people suffering from severe cramps, heavy periods, and anemia.

Breakup by End-Use:

Hospitals
Gynaecology Clinics
Community Healthcare
Others

On the basis of end-use segment, the report has segregated the market into hospitals, gynaecology clinics, community healthcare and others.

Breakup by Region:

Europe
North America
Asia Pacific
Middle East and Africa
Latin America

North America enjoys the leading position in the market share due to the increasing number of mistimed and unplanned pregnancy cases in the region.

Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Actavis, Bayer, Teva Pharmaceuticals, Allergan, Eurogine, OCON Medical, Pregna, HLL Lifecare, HRA Pharma, ANI Pharmaceuticals, Besins HealthCare, SMB, etc

This report provides a deep insight into the global intrauterine devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the intrauterine devices industry in any manner.

Key Questions Answered in This Report
1. What was the size of the global intrauterine devices market in 2022?
2. What is the expected growth rate of the global intrauterine devices market during 2023-2028?
3. What are the key factors driving the global intrauterine devices market?
4. What has been the impact of COVID-19 on the global intrauterine devices market?
5. What is the breakup of the global intrauterine devices market based on the product?
6. What are the key regions in the global intrauterine devices market?
7. Who are the key players/companies in the global intrauterine devices market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intrauterine Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by End-Use
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 Weaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.9.1 Overview
5.9.2 Research and Development
5.9.3 Raw Material Procurement
5.9.4 Manufacturing
5.9.5 Marketing
5.9.6 Distribution
5.9.7 End-Use
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
6 Market Breakup by Product
6.1 Hormonal Intrauterine Device
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Copper Intrauterine Device
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by End-Use
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Gynaecology Clinics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Community Healthcare
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 Europe
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 North America
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Intrauterine Devices Manufacturing Process
9.1 Product Overview
9.2 Raw Material Requirements
9.3 Manufacturing Process
9.4 Key Success and Risk Factors
10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
10.3 Profiles of Key Players
10.3.1 Actavis
10.3.2 Bayer
10.3.3 Teva Pharmaceuticals
10.3.4 Allergan
10.3.5 ANI Pharmaceuticals
10.3.6 Eurogine
10.3.7 OCON Medical
10.3.8 Pregna
10.3.9 SMB Corporation
10.3.10 HLL Lifecare
10.3.11 HRA Pharma
10.3.12 Besins HealthCare



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 子宮内避妊器具(IUD)の世界市場2022-2028:産業動向、シェア、規模、成長、機会・予測(Intrauterine Devices (IUD) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆